Comparison of Cytokine Level in Synovial Fluid between Successful and Unsuccessful Cases in Arthrocentesis of the Temporomandibular Joint

Journal of Oral and Maxillofacial Surgery

Volumn 62, Issue 3, 2004, Pages 284-287

  Nishimura, Masaaki ^a   Segami, Natsuki ^b   Kaneyama, Keiseki ^b   Sato, Jun ^b   Fujimura, Kazumza ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTHROCENTESIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN CONTENT; SYNOVIAL FLUID; SYNOVIAL FLUID LEVEL; SYNOVITIS; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 1542376877     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2003.08.012     Document Type: Article

References (38)

1. Nitzan DW, Dolwick MF, Martinez GA: Temporomandibular joint arthrocentesis: A simplified treatment for severe, limited mouth opening. J Oral Maxillofac Surg 49:1163, 1991
2. Dimitroulis G, Dolwick MF, Martinez GA: Temporomandibular joint arthrocentesis and lavage for the treatment of closed lock: A follow-up study. Br J Oral Maxillofac Surg 33:23, 1995
3. Nitzan DW: Arthrocentesis for management of severe closed lock of the temporomandibular joint. Oral Maxillofac Surg Clin North Am 6:245, 1994
4. Murakami K, Hosaka H, Moriya Y, et al: Short-term treatment outcome study for the management of temporomandibular joint closed lock: A comparison of arthrocentesis to nonsurgical therapy and arthroscopic lysis and lavage. Oral Surg Oral Med Oral Pathol 80:253, 1995
5. Ness GM, Crawford KC: Temporomandibular joint arthrocentesis for acute or chronic closed lock. J Oral Maxillofac Surg 54:112, 1996 (suppl 3)
6. Hosaka H, Murakami K, Goto K, et al: Outcome of arthrocentesis for temporomandibular joint with closed lock at 3 years follow-up. Oral Surg Oral Med Oral Pathol 82:501, 1996
7. Fridrich KL, Wise JM, Zeitler DL: Prospective comparison of arthroscopy and arthrocentesis for temporomandibular joint disorders. J Oral Maxillofac Surg 54:816, 1996
8. Nitzan DW, Samson B, Better H: Long-term of arthrocentesis for sudden-onset, persistent, severe closed lock of the temporomandibular joint. J Oral Maxillofac Surg 55:151, 1997
9. Frost DE, Kendell BD: The use of arthrocentesis for treatment of temporomandibular joint disorders. J Oral Maxillofac Surg 57:583, 1999
10. Nishimura M, Segami N, Kaneyama K, et al: Prognostic factors in arthrocentesis of the temporomandibular joint: Evaluation of 100 patients with internal derangement. J Oral Maxillofac Surg 59:874, 2001
11. Sander NA, Buckley MJ, Cillo JE, et al: Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangement. J Oral Maxillofac Surg 56:534, 1998
12. Shafer DM, Assael L, White LB, et al: Tumor necrosis factor-α as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxillofac Surg 52:786, 1994
13. Fu K, Ma X, Zhang Z, et al: Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg 53:424, 1995
14. Fu KY, Ma XC, Zhang ZK, et al: Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain 9:131, 1995
15. Kubota E, Imamura H, Kubota T, et al: Interleukin 1β and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 55:20, 1997
16. Kubota E, Kubota T, Matsumoto J, et al: Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 56:192, 1998
17. Takahashi T, Kondoh T, Fukuda M, et al: Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:135, 1998
18. Nishimura M, Segami N, Kaneyama K, et al: Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg 40:68, 2002
19. Kaneyama K, Segami N, Nishimura M, et al: Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br J Oral Maxillofac Surg 40:418, 2002
20. Whiteside TL: Cytokine measurements and interpretation of cytokine assays in human disease. J Clin Immunol 14:327, 1994
21. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 772:1627, 1991
22. Arend WP, Dayer JM: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33:305, 1990
23. Nouri AME, Panayi GS, Goodman SM: Cytokines and the chronic inflammation of rheumatic disease. I. Clin Exp Immunol 55:295, 1984
24. Hopkins SJ, Humphreys M, Jayson MIV: Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 73:422, 1988
25. Hopkins SJ, Meager A: Cytokines in synovial fluid. II. The presence of tumor necrosis factor and interferon. Clin Exp Immunol 73:88, 1988
26. Waage A, Kaufman C, Espevik T, et al: Interleukin-6 in synovial fluid from patients with arthritis. Clin Immumol Immunopathol 50:394, 1989
27. Di Giovine FS, Nuki G, Duff GW: Tumor necrosis factor in synovial exudates. Ann Rheum Dis 47:768, 1988
28. Verburgh CA, Hart MHL, Aarden LA, et al: Interleukin-8 (IL-8) in synovial fluid of rheumatoid and nonrheumatoid joint effusions. Clin Rheumatol 12:494, 1993
29. Arner EC, Pratta MA: Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture. Arthritis Rheum 32:288, 1989
30. Okada Y, Shinmei M, Tanaka O, et al: Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 66:680, 1992
31. Shinmei M, Masuda K, Kikuchi T, et al: The role of cytokines in chondrocyte mediated cartilage degradation. J Rheumatol 16:32, 1989
32. Shinmei M, Masuda K, Kikuchi T, et al: Interleukin 1, tumor necrosis factor, and interleukin 6 as mediators of cartilage destruction. Semin Arthritis Rheum 18:27, 1989
33. Saklatvala J: Tumor necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547, 1986
34. Wilbrink B, Nietfeld JJ, Den Otter W, et al: Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage. Br J Rheumatol 30:265, 1991
35. Henderson B, Pettipher ER: Arthritogenic actions of recombinant IL-1 and tumor necrosis factor alpha in the rabbit: Evidence for synergistic interactions between cytokines in vivo. Clin Exp Rheumatol 75:306, 1989
36. Shinmei M, Masuda K, Kikuchi T, et al: Production of cytokines by chondrocytes and its role in proteoglycan degradation. J Rheumatol 18:89, 1991
37. Malfait AM, Verbruggen G, Veys EM, et al: Comparative and combined effects of interleukin 6, interleukin 1 beta, tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose. J Rheumatol 21:314, 1994
38. Shingu M, Miyauchi S, Nagai Y, et al: The role of IL-4 and IL-6 in IL-dependent cartilage matrix degradation. Br J Rheumatol 34:101, 1995